SAGE
Sage Therapeutics
SAGE
SAGE
Delisted
SAGE was delisted on the 30th of July, 2025.
199 hedge funds and large institutions have $2.04B invested in Sage Therapeutics in 2022 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 68 increasing their positions, 59 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
4% less funds holding
Funds holding: 208 → 199 (-9)
23% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 30
Holders
199
Holding in Top 10
2
Calls
$23.4M
Puts
$6.52M
Top Buyers
| 1 | +$27.2M | |
| 2 | +$22.7M | |
| 3 | +$17.4M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$16.6M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$13.3M |
Top Sellers
| 1 | -$24M | |
| 2 | -$17.9M | |
| 3 | -$11.8M | |
| 4 |
Morgan Stanley
New York
|
-$9.11M |
| 5 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$5.55M |